Yale University

Publications

Filters: Keyword is RNA, Viral  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
A
Abdool Karim, Salim S., Kogieleum Naidoo, Anneke Grobler, Nesri Padayatchi, Cheryl Baxter, Andrew Gray, Tanuja Gengiah, Gonasagrie Nair, Sheila Bamber, Aarthi Singh et al. "Timing of initiation of antiretroviral drugs during tuberculosis therapy." The New England journal of medicine 362, no. 8 (2010): 697-706. Abstract
Abraham, Alison G., Bryan Lau, Steven Deeks, Richard D. Moore, Jinbing Zhang, Joseph Eron, Richard Harrigan, John M. Gill, Mari Kitahata, Marina Klein et al. "Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america." American journal of epidemiology 174, no. 6 (2011): 727-35. Abstract
Althoff, Keri N., Kate Buchacz, Irene H. Hall, Jinbing Zhang, David B. Hanna, Peter Rebeiro, Stephen J. Gange, Richard D. Moore, Mari M. Kitahata, Kelly A. Gebo et al. "U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008." Annals of internal medicine 157, no. 5 (2012): 325-35. Abstract
Althoff, Keri N., Amy C. Justice, Stephen J. Gange, Steven G. Deeks, Michael S. Saag, Michael J. Silverberg, John M. Gill, Bryan Lau, Sonia Napravnik, Ellen Tedaldi et al. "Virologic and immunologic response to HAART, by age and regimen class." AIDS (London, England) 24, no. 16 (2010): 2469-79. Abstract
Altice, Frederick L., Jo Anne Mezger, John Hodges, Robert D. Bruce, Adrian Marinovich, Mary Walton, Sandra A. Springer, and Gerald H. Friedland. "Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 38 Suppl 5 (2004): S376-87. Abstract
Altice, Frederick L., Douglas R. Bruce, Gregory M. Lucas, Paula J. Lum, Todd P. Korthuis, Timothy P. Flanigan, Chinazo O. Cunningham, Lynn E. Sullivan, Pamela Vergara-Rodriguez, David A. Fiellin et al. "HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S22-32. Abstract
Altice, Frederick L., Duncan Smith-Rohrberg Maru, Douglas R. Bruce, Sandra A. Springer, and Gerald H. Friedland. "Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 45, no. 6 (2007): 770-8. Abstract
Altice, Frederick L., and Sandra A. Springer. "DAART for human immunodeficiency virus-infected patients: Studying subjects not at risk for nonadherence and use of untested interventions." Archives of internal medicine 170, no. 1 (2010): 109-10.
B
Bermejo-Martin, Jesus F., Raul Ortiz de Lejarazu, Tomas Pumarola, Jordi Rello, Raquel Almansa, Paula Ramírez, Ignacio Martin-Loeches, David Varillas, Maria C. Gallegos, Carlos Serón et al. "Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza." Critical care (London, England) 13, no. 6 (2009): R201. Abstract
Braithwaite, Scott R., Michael J. Kozal, Chung Chou H. Chang, Mark S. Roberts, Shawn L. Fultz, Matthew Bidwell Goetz, Cynthia Gibert, Maria Rodriguez-Barradas, Larry Mole, and Amy C. Justice. "Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies." AIDS (London, England) 21, no. 12 (2007): 1579-89. Abstract
Bruce, Robert D., and Frederick L. Altice. "Case series on the safe use of buprenorphine/naloxone in individuals with acute hepatitis C infection and abnormal hepatic liver transaminases." The American journal of drug and alcohol abuse 33, no. 6 (2007): 869-74. Abstract
Burman, William, Birgit Grund, Jacqueline Neuhaus, John Douglas, Gerald Friedland, Edward Telzak, Robert Colebunders, Nicholas Paton, Martin Fisher, and Cornelis Rietmeijer. "Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial." Journal of acquired immune deficiency syndromes (1999) 49, no. 2 (2008): 142-50. Abstract
C
Cassol, Edana, Taryn Page, Anisa Mosam, Gerald Friedland, Chris Jack, Umesh Lalloo, Joe Kopetka, Bruce Patterson, Tonya Esterhuizen, and Hoosen M. Coovadia. "Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8." The Journal of infectious diseases 191, no. 3 (2005): 324-32. Abstract
F
Farber, Steven, Janet Tate, Cyndi Frank, David Ardito, Michael Kozal, Amy C. Justice, and R. Scott Braithwaite. "A study of financial incentives to reduce plasma HIV RNA among patients in care." AIDS and behavior 17, no. 7 (2013): 2293-300. Abstract
Feucht, Ute Dagmar, Brian Forsyth, and Mariana Kruger. "False-positive HIV DNA PCR testing of infants: implications in a changing epidemic." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 102, no. 3 Pt 1 (2012): 149-52. Abstract
G
Genberg, Becky L., Ira B. Wilson, David R. Bangsberg, Julia Arnsten, Kathy Goggin, Robert H. Remien, Jane Simoni, Robert Gross, Nancy Reynolds, Marc Rosen et al. "Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America." AIDS (London, England) 26, no. 11 (2012): 1415-23. Abstract
H
Heimer, R., K. Khoshnood, B. Jariwala-Freeman, B. Duncan, and Y. Harima. "Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens." The Journal of infectious diseases 173, no. 4 (1996): 997-1000. Abstract
Hudelson, Sarah E., Natalia Marlowe, Wei Huang, Robert Bruce, Jessica D. Church, Marla Husnik, Deborah Donnell, Thomas Coates, Brooks J. Jackson, Margaret Chesney et al. "Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors." AIDS research and human retroviruses 25, no. 7 (2009): 701-5. Abstract
I
Ing, Eileen C., Jason W. Bae, Duncan Smith-Rohrberg Maru, and Frederick L. Altice. "Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy." AIDS and behavior 17, no. 1 (2013): 113-21. Abstract
J
Justice, Amy C., K. A. McGinnis, M. Skanderson, C. C. Chang, C. L. Gibert, M. B. Goetz, D. Rimland, M. C. Rodriguez-Barradas, K. K. Oursler, S. T. Brown et al. "Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers." HIV medicine 11, no. 2 (2010): 143-51. Abstract
K
Kerndt, Peter R., Robert Dubrow, Getahun Aynalem, Kenneth H. Mayer, Curt Beckwith, Robert H. Remien, Hong-Ha M. Truong, Apurva Uniyal, Michael Chien, Ronald A. Brooks et al. "Strategies used in the detection of acute/early HIV infections. The NIMH Multisite Acute HIV Infection Study: I." AIDS and behavior 13, no. 6 (2009): 1037-45. Abstract
Kimmel, April D., Sue J. Goldie, Rochelle P. Walensky, Elena Losina, Milton C. Weinstein, David A. Paltiel, Hong Zhang, and Kenneth A. Freedberg. "Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients." Antiviral therapy 10, no. 1 (2005): 41-52. Abstract
Kitahata, Mari M., Stephen J. Gange, Alison G. Abraham, Barry Merriman, Michael S. Saag, Amy C. Justice, Robert S. Hogg, Steven G. Deeks, Joseph J. Eron, John T. Brooks et al. "Effect of early versus deferred antiretroviral therapy for HIV on survival." The New England journal of medicine 360, no. 18 (2009): 1815-26. Abstract
L
Lanoy, Emilie, Margaret May, Amanda Mocroft, Andrew Phillip, Amy Justice, Geneviève Chêne, Hansjakob Furrer, Timothy Sterling, Antonella d'Arminio Monforte, Lluís Force et al. "Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements." AIDS (London, England) 23, no. 16 (2009): 2199-208. Abstract
M
Maru, Duncan Smith-Rohrberg, Robert Douglas Bruce, Mary Walton, Sandra A. Springer, and Frederick L. Altice. "Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial." Journal of acquired immune deficiency syndromes (1999) 50, no. 2 (2009): 176-81. Abstract
May, Margaret, Jonathan A. C. Sterne, Caroline Sabin, Dominique Costagliola, Amy C. Justice, Rodolphe Thiébaut, John Gill, Andrew Phillips, Peter Reiss, Robert Hogg et al. "Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies." AIDS (London, England) 21, no. 9 (2007): 1185-97. Abstract
d'Arminio Monforte, Antonella, Caroline A. Sabin, Andrew Phillips, Jonathan Sterne, Margaret May, Amy Justice, Francois Dabis, Sophie Grabar, Bruno Ledergerber, John Gill et al. "The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy." Archives of internal medicine 165, no. 4 (2005): 416-23. Abstract
Mugavero, Michael J., Margaret May, Ross Harris, Michael S. Saag, Dominique Costagliola, Matthias Egger, Andrew Phillips, Huldrych F. Günthard, Francois Dabis, Robert Hogg et al. "Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?" AIDS (London, England) 22, no. 18 (2008): 2481-92. Abstract
P
Paintsil, Elijah, Sergei V. Verevochkin, Elena Dukhovlinova, Linda Niccolai, Russell Barbour, Edward White, Olga V. Toussova, Louis Alexander, Andrei P. Kozlov, and Robert Heimer. "Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection." Addiction (Abingdon, England) 104, no. 11 (2009): 1881-90. Abstract
Pol, Stanislas, Reem H. Ghalib, Vinod K. Rustgi, Claudia Martorell, Greg T. Everson, Harvey A. Tatum, Christophe Hézode, Joseph K. Lim, Jean-Pierre Bronowicki, Gary A. Abrams et al. "Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial." The Lancet infectious diseases 12, no. 9 (2012): 671-7. Abstract
Pollard, Richard B., Camlin Tierney, Diane Havlir, Pablo Tebas, Lawrence Fox, Laura Smeaton, Douglas Richman, and Gerald H. Friedland. "A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298)." AIDS research and human retroviruses 18, no. 10 (2002): 699-704. Abstract
R
Raffanti, Stephen P., Jennifer S. Fusco, Beth H. Sherrill, Nellie I. Hansen, Amy C. Justice, Richard D'Aquila, Wendy J. Mangialardi, and Gregory P. Fusco. "Effect of persistent moderate viremia on disease progression during HIV therapy." Journal of acquired immune deficiency syndromes (1999) 37, no. 1 (2004): 1147-54. Abstract
Rich, J. D., B. P. Dickinson, J. M. Carney, A. Fisher, and R. Heimer. "Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection." AIDS (London, England) 12, no. 17 (1998): 2345-50. Abstract
S
Seage, George R., Elena Losina, Sue J. Goldie, David A. Paltiel, April D. Kimmel, and Kenneth A. Freedberg. "The relationship of preventable opportunistic infections, HIV-1 RNA, and CD4 Cell counts to chronic mortality." Journal of acquired immune deficiency syndromes (1999) 30, no. 4 (2002): 421-8. Abstract
Simoni, Jane M., Wei-Ti Chen, David Huh, Karen I. Fredriksen-Goldsen, Cynthia Pearson, Hongxin Zhao, Cheng-Shi Shiu, Xin Wang, and Fujie Zhang. "A preliminary randomized controlled trial of a nurse-delivered medication adherence intervention among HIV-positive outpatients initiating antiretroviral therapy in Beijing, China." AIDS and behavior 15, no. 5 (2011): 919-29. Abstract
T
Tetrault, Jeanette M., Janet P. Tate, Kathleen A. McGinnis, Joseph L. Goulet, Lynn E. Sullivan, Kendall Bryant, Amy C. Justice, and David A. Fiellin. "Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone." Alcoholism, clinical and experimental research 36, no. 2 (2012): 318-24. Abstract
W
Walensky, Rochelle P., Sue J. Goldie, Paul E. Sax, Milton C. Weinstein, David A. Paltiel, April D. Kimmel, George R. Seage, Elena Losina, Hong Zhang, Runa Islam et al. "Treatment for primary HIV infection: projecting outcomes of immediate, interrupted, or delayed therapy." Journal of acquired immune deficiency syndromes (1999) 31, no. 1 (2002): 27-37. Abstract